DexCom

DexCom

Yahoo Finance • 11 hours ago

Guardant Health (GH) Could Be 17% Undervalued As Board Appointment Tests Valuation

Guardant Health (GH) has drawn fresh attention after appointing Kevin Sayer, former Dexcom CEO and current Executive Chairman, to its board of directors. The move is raising new questions about where the stock's story goes next. Guardant... Full story

Yahoo Finance • 11 hours ago

Will Shield Award Recognition Change Guardant Health Stock Narrative

Guardant Health reported that its Shield blood test for colorectal cancer screening received the 2026 Prix Galien USA Award for Best Medical Technology, recognizing the first FDA approved blood test for primary colorectal cancer screening... Full story

Yahoo Finance • 2 days ago

Biosensors - Global Strategic Business Report: Secure Share of the $53.7 Billion Market by 2030 as Abbott, Dexcom, Medtronic and Masimo Accelerate Wearable and AI Diagnostics

Company Logo Capitalize on demand for wearable, point-of-care biosensors driven by chronic disease monitoring, nanotechnology, personalized medicine, and food and environmental safety. Dublin, Nov. 03, 2026 (GLOBE NEWSWIRE) -- "Biosensor... Full story

Yahoo Finance • 6 days ago

Dexcom Shakes Off Abbott-Tied Malaise As U.S. Wearables Market Takes Off

Dexcom, known for its G-series of diabetes wearables, topped September-quarter expectations late Thursday, leading to a guidance hike. Continue Reading... Full story

Yahoo Finance • 7 days ago

Dexcom anticipates $5.20B-$5.25B 2026 revenue while authorizing another $1B buyback

Earnings Call Insights: DexCom (DXCM) Q3 2026 MANAGEMENT VIEW * "Today, we reported third quarter revenue growth of 11% compared to the third quarter of 2025" (President, CEO & Director Jacob Leach), adding, "We once again gained share... Full story

Yahoo Finance • 16 days ago

Abbott (ABT): Can Libre Keep Growing as Glucose Monitoring Becomes More Competitive?

Abbott Laboratories (NYSE:ABT) benefits each time a patient replaces a glucose sensor. Continuous glucose monitoring, or CGM, sales grew 9.5% excluding currency effects in the second quarter of 2026, versus 7.6% in the first quarter. The i... Full story

Yahoo Finance • 17 days ago

Global Wearable Electronics Market Report 2026-2036 | AI, Extended Reality, and Digital Health Drive New Growth and Investment Opportunities

Company Logo Dublin, Oct. 19, 2026 (GLOBE NEWSWIRE) -- "The Global Wearable Electronics Market 2026-2036" has been added to ResearchAndMarkets.com's offering. The global wearable electronics market is undergoing a structural transformati... Full story

Yahoo Finance • 20 days ago

Vaso Stock Surges 149% in a Year: What's Behind the Rally?

Vaso Corporation's VASO investors have been experiencing some short-term gains from the stock lately. Shares of the Plainview, NY-based diversified healthcare-focused company gained 149% in the past year compared with the industry's 8.9% r... Full story

Yahoo Finance • 23 days ago

mHealth Solutions Market Forecasts Growth from $109.05B (2026) to $275.44B by 2031, Profiling Philips, Medtronic, Abbott, Dexcom, ResMed & 20 Other Key Players

Company Logo 388-Page Report Delivers 2025 Market Share Rankings, Vendor Valuation Metrics and End-User Buying Criteria as Asia Pacific Emerges as the Fastest-Growing Region Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "mHealth Solutions Ma... Full story

Yahoo Finance • 25 days ago

Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus

Wall Street regained some momentum on Friday, after the AI trade came under pressure on Thursday. The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-news%7Csection%3Amarket-news%7Csection_asset%3Aful... Full story

Yahoo Finance • 28 days ago

Citi reiterates these 2 medtech stocks as its top picks in the sector

Investing.com-- Citi reiterated its top picks in the medtech sector, highlighting Abbott Laboratories and Dexcom as standout opportunities while pointing to diverging fortunes across the industry. Before you buy NVIDIA: our AI model's sto... Full story

Yahoo Finance • 30 days ago

Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading

Dexcom U's season five roster features 27 athletes with Type 1 diabetes across 13 sports, marking the program's largest roster to date.Each athlete relies on Dexcom continuous glucose monitors like Dexcom G7 or Dexcom G7 15 Day to manage t... Full story

Yahoo Finance • last month

2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds

2 Large-Cap Stocks with Exciting Potential and 1 Facing Headwinds Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth i... Full story

Yahoo Finance • last month

DexCom (DXCM) Promotes Former CFO Jereme Sylvain To Chief Operating Officer

DexCom (NasdaqGS:DXCM) has promoted former Chief Financial Officer Jereme Sylvain to EVP and Chief Operating Officer. Healthcare executive Glenn S. Boehnlein has joined DexCom's board of directors, adding external industry experience to go... Full story

Yahoo Finance • last month

2 Nasdaq 100 Stocks for Long-Term Investors and 1 We Turn Down

2 Nasdaq 100 Stocks for Long-Term Investors and 1 We Turn Down The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in the index face challenges like profitability conc... Full story

Yahoo Finance • last month

Global Wearable Biosensors Market Trends, Strategies and Forecast to 2036 Featuring Abbott Labs, Dexcom, Medtronic, Roche, Apple, Samsung Electronics Co., Garmin and Other Key Players

Company Logo Dublin, Sept. 21, 2026 (GLOBE NEWSWIRE) -- "Wearable Biosensors Market - Global Forecast to 2036" has been added to ResearchAndMarkets.com's offering. According to the research report, the global wearable biosensors market... Full story

Yahoo Finance • 2 months ago

Notable healthcare headlines for the week: Novo Nordisk, GE HealthCare, and Eli Lilly in focus

Wall Street's major market averages finished mixed as Treasury yields rebounded, rekindling concerns about a deteriorating macroeconomic backdrop. The S&P 500 (SP500 [https://seekingalpha.com/symbol/SP500#source=url_first_level%3Amarket-n... Full story

Yahoo Finance • 2 months ago

2 Unpopular Stocks That Should Get More Attention and 1 We Question

2 Unpopular Stocks That Should Get More Attention and 1 We Question Wall Street's bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate... Full story

Yahoo Finance • 2 months ago

Stock futures rise as Fed rate decision takes center stage

[Wall Street street sign in Manhattan financial district] Alexey_Fedoren Stock index futures were higher on Wednesday as investors focused on the Federal Reserve's interest rate decision. Dow futures (INDU [https://seekingalpha.com/symbo... Full story

Yahoo Finance • 2 months ago

Dexcom Appoints Glenn Boehnlein to Board of Directors

SAN DIEGO, September 10, 2026--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Glenn Boehnlein to its Board of Directors, effective September 10, 2026. Mr. Boehnlein... Full story